addiction recovery ebulletin diabetes drug metformin
May 27, 2020 – The U.S Food and Drug Administration said on Wednesday it had found high levels of a possible cancer-causing impurity in some versions of the popular diabetes drug metformin.
The agency is reaching out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels and will take appropriate action, a spokesman for the FDA said in an emailed statement.
Bloomberg, which first reported the FDA’s findings, said that some recalls of metformin were expected as soon as this week, citing a person familiar with the matter.
Online pharmacy Valisure said in March that its independent tests showed high levels of NDMA in metformin made by 11 companies, including Amneal Pharmaceuticals Inc and Aurobindo Pharma Ltd.
“I don’t really do endorsements. I’m not shy about sharing my views, but I hate…
THE LOSS LINGERS – Oct. 24, 2024 - Perry's younger sister, Caitlin Morrison, 43, and his…
AUDIO – PROFITS BEFORE PEOPLE? – Oct. 25, 2025 - Big addiction treatment “campuses” aren’t…
VIDEO – MUSICAL INTERLUDE – 50,272,624 views - June 17, 2022 - As featured in…
VIDEO – JUNKIES LIVES MATTER – Oct. 25, 2024 - According to ChatGPT, Orange County,…
THE COMEBACK KID – Oct. 2024 - I celebrated my 70th birthday this year, on…